Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Go back to Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
(NYSE: LCTX) Delayed: 1.03 --0 (-0%)
Previous Close $1.03    52 Week High
Open $1.02    52 Week Low
Day High $1.06    P/E N/A 
Day Low $1.00    EPS
Volume 3,209,251       

(NYSE: LCTX) Delayed: 1.03 --0 (-0%)
Previous Close $1.03    52 Week High
Open $1.02    52 Week Low
Day High $1.06    P/E N/A 
Day Low $1.00    EPS
Volume 3,209,251